Aspen Pharmacare Holdings Ltd. rallied the most in a quarter-century after Africa’s biggest drugmaker said it will sell its assets in the Asia-Pacific region excluding China to an Australian private equity firm for 26.5 billion rand ($1.6 billion).
Aspen Pharmacare plant in Gqeberha, South Africa.
Photographer: Waldo Swiegers/Bloomberg
The sale of the assets in Australia, Hong Kong, Malaysia, Taiwan and the Philippines to BGH Capital (Pty) Ltd. represents an enterprise value that’s about 11 times normalized earnings before interest, tax, depreciation and amortization reported in 2025, the Durban, South Africa-based company said in a statement Monday.
The stock surged 24%, the most since January 2000, paring the ...
